LabCorp To Present at the Goldman Sachs Healthcare Conference - Reiterates 2008 Guidance and Updates Preliminary 2009 Guidance

BURLINGTON, N.C., Jan 06, 2009 (BUSINESS WIRE) -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that David P. King, Chief Executive Officer, is scheduled to speak at the Goldman Sachs Healthcare Conference in New York City, NY.

National Jewish Health and LabCorp to Collaborate on Companion Diagnostics Opportunities

DENVER & BURLINGTON, N.C., Dec 10, 2008 (BUSINESS WIRE) -- National Jewish Health and Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) (LabCorp) have reached an agreement to collaborate in the development and commercialization of molecular diagnostic tests in support of

LabCorp is Scheduled to Present at the 20th Annual Piper Jaffray Health Care Conference

BURLINGTON, N.C., Nov 24, 2008 (BUSINESS WIRE) -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that William B. (Brad) Hayes, Executive Vice President and Chief Financial Officer, is scheduled to speak at the 20th Annual Piper Jaffray Health Care Conference

LabCorp Launches Tumor MGMT Gene Methylation Testing

BURLINGTON, N.C., Nov 19, 2008 (BUSINESS WIRE) -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) announced today that it has introduced its MGMT gene methylation assay using Methylation-Specific PCR technology licensed from OncoMethylome Sciences (Euronext Brussels: ONCOB;

LabCorp is Scheduled to Present at the Credit Suisse 2008 Global Healthcare Conference

BURLINGTON, N.C.--(BUSINESS WIRE)--Nov. 7, 2008--Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that William B. (Brad) Hayes, Executive Vice President and Chief Financial Officer, is scheduled to speak at the Credit Suisse 2008 Global Healthcare Conference in

LabCorp to be the First National Commercial Lab to Offer Roche's COBAS(R) TaqMan(R) HBV Test

BURLINGTON, N.C., Nov 06, 2008 (BUSINESS WIRE) -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) announces that it will be the first national clinical laboratory to offer HBV PCR testing using a newly FDA approved assay, the Roche COBAS(R) TaqMan(R) HBV Test.

Mubadala Healthcare and Laboratory Corporation of America Holdings Agree to Establish a National Reference Laboratory in Abu Dhabi

ABU DHABI, U.A.E. & BURLINGTON, N.C., Nov 04, 2008 (BUSINESS WIRE) -- Mubadala Healthcare, the specialist division of Mubadala Development Company, and Laboratory Corporation of America Holdings, more commonly known as LabCorp (NYSE: LH), today announced their agreement to establish the National

Laboratory Corporation of America(R) Holdings Announces 2008 Third Quarter Results

Strong Revenue Growth and Success of Collection Initiatives Drive Operating Cash Flow of $194.4 Million in the Quarter and $565.6 Million Year to Date BURLINGTON, N.C.--(BUSINESS WIRE)-- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE:LH) today announced results for the quarter

Conversion Right Triggered for LabCorp's Liquid Yield Option(TM) Notes Due 2021 and Zero Coupon Convertible Subordinated Notes Due 2021

BURLINGTON, N.C.--(BUSINESS WIRE)-- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE:LH) announced today that its zero coupon subordinated Liquid Yield Option(TM) Notes due 2021 (LYONs) and Zero Coupon Convertible Subordinated Notes due 2021 (Zero Coupon Notes) may be converted as

LabCorp is Scheduled to Present at the UBS 2008 Global Life Sciences Conference

BURLINGTON, N.C.--(BUSINESS WIRE)--Sept. 19, 2008--Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that David P. King, Chief Executive Officer and William B. (Brad) Hayes, Executive Vice President and Chief Financial Officer, are scheduled to speak at the UBS